Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2022, 4(9); doi: 10.25236/IJFM.2022.040909.

Research Progress on the Taxonomy of Symptoms of Polycystic Ovary Syndrome

Author(s)

Li Yi1, Xiaoping Cui1, Gege Li1, Mingzhu Huang1, Juanjuan Zhang1, Xinchun Xiao2, Xia Liu2

Corresponding Author:
Xiaoping Cui
Affiliation(s)

1Shaanxi University of Chinese Medicine, No. 1, Middle Section of Century Avenue, Chenyangzhai, Qindu District, Xianyang City, Shaanxi Province, China, 712046

2Affiliated Hospital of Shaanxi University of Chinese Medicine, Deputy No. 2, Weiyang West Road, Qindu District, Xianyang City, Shaanxi Province, China, 712046

Abstract

Polycystic ovary syndrome is a common gynecological disorder of reproductive endocrine metabolism. Because of its increasing incidence year by year, it seriously affects the physical and mental health of women. There is a lack of a unified classification of Traditional Chinese Medicine symptoms, and it is crucial to standardize the classification of Traditional Chinese Medicine symptoms. The purpose of this paper is to summarize the literature on Polycystic Ovary Syndrome syndromes in the past 10 years, and to outline the progress of research on the classification of polycystic ovary syndrome syndromes from the perspectives of Chinese medicine pathogenesis theory, medical case experiences, distribution patterns of syndromes and relevant experimental indicators. We also propose issues and suggestions for the promotion of such studies in order to provide a more scientific basis for the further development of the taxonomy of Polycystic Ovary Syndrome symptoms and the characteristic treatment of Traditional Chinese Medicine.

Keywords

Polycystic ovary syndrome, Symptoms, Pathogenesis

Cite This Paper

Li Yi, Xiaoping Cui, Gege Li, Mingzhu Huang, Juanjuan Zhang, Xinchun Xiao, Xia Liu. Research Progress on the Taxonomy of Symptoms of Polycystic Ovary Syndrome. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 9: 45-50. https://doi.org/10.25236/IJFM.2022.040909.

References

[1] Peng Mengfan, Liu Baosong, Miao Mingsan. Theoretical discussion on the treatment of polycystic ovary syndrome by kidney tonic method [J]. Chinese Journal of Experimental Formulary, 2019, 25(06): 204-209.

[2] Qiao Jie, Qi Xin Yu, Xu Yalan, et al. Focus on polycystic ovary syndrome, an important reproductive endocrine disorder affecting women's health[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2020, 36 (01): 1-9.

[3] Yu Jin, Yu Chaoqin, Hou Lihui, et al. Research and application of evidence and treatment protocols for polycystic ovary syndrome[J]. Chinese Journal of Integrative Medicine, 2021, 41(02): 246-251.

[4] Zhang Meiwei, Hou Lihui, Li Yan, et al. A collection of Hou Lihui's experience in preconception interventions for the treatment of polycystic ovary syndrome infertility[J]. Chinese Journal of Traditional Chinese Medicine, 2020, 35(07): 3447-3451.

[5] Liu Yuxin, Hou Lihui, Wu Xiaoke. Etiology and pathogenesis of polycystic ovary syndrome in Chinese medicine[J]. Tianjin Chinese medicine, 2009, 26(02): 123-124.

[6] Xu Yang, Zhang Haolin, Wang Chuanshe, et al. Research progress on the influence of emotional and psychological factors on the development of polycystic ovary syndrome[J]. Chinese Journal of Traditional Chinese Medicine, 2019, 34(09): 4193-4196.

[7] Chen Xu. Discussing the pathogenesis of polycystic ovary syndrome from "deficiency of both kidney and spleen, phlegm and stagnation of ligaments"[J]. Chinese Journal of Basic Chinese Medicine, 2016, 22(02): 267-269.

[8] Zhang Yilei, Pan Wen, Wang Yongjuan. Advances in Chinese and Western medicine research on the etiology and pathogenesis of polycystic ovary syndrome[J]. Chinese Journal of Basic Chinese Medicine, 2016, 22(07): 1004-1006.

[9] Changjiu, Li Xiaojun. Exploration of the association of polycystic ovary syndrome with phlegm-dampness and blood stasis pathogenesis[J]. Chinese Journal of Basic Chinese Medicine, 2015, 21(09): 1128-1130+1145.

[10] Zhang Wen, Li Na, Xu Zhaoxia. Advances in the research of Chinese medical evidence and treatment of polycystic ovary syndrome[J]. World Science and Technology - Modernization of Chinese Medicine, 2018, 20(05): 810-815.

[11] He Huiling, Sun Yu. Zhu Yunlong's experience in treating polycystic ovary syndrome by promoting lung, benefiting kidney and resolving blood stasis[J]. Chinese Journal of Basic Chinese Medicine, 2020, 26(07): 995-997.

[12] Wang Xin, Mo Chongming. The theory of damp-heat polycystic ovary syndrome: division and elimination and drainage[J]. Chinese Journal of Traditional Chinese Medicine, 2016, 34(02): 369-372.

[13] Xie Lu, Pan Biqi, Zheng Xiaohong, et al. Analysis of polycystic ovary syndrome from the theory of "circular motion"[J]. Shi-Zhen Guomao, 2016, 27(07): 1696-1697.

[14] Chang Hui, Wang Xijun, Wu Xiaoke. Exploration of the TCM pathogenesis of polycystic ovary syndrome based on the theory of reproductive organs and signs[J]. World Science and Technology - Modernization of Chinese Medicine, 2018, 20(07): 1192-1196.

[15] Huang Cancan, He Ruiqi, Cui Nan, et al. On the treatment of non-obese polycystic ovary syndrome based on the "fire of Dragon thunder" theory [J]. Shi Zhen Guoyi Sinopharm, 2020, 31(10): 2447-2449.

[16] Meng Yunxiao, Sui Juan, Fang Qingxia, et al. Clinical experience of Professor Chen Ruixue in the treatment of polycystic ovary syndrome[J]. Chinese Journal of Clinical Physicians, 2022, 50(02): 247-250.

[17] Liu Yiru, Zhao Wei, Cheng pei. Professor Zhao Wei's experience in treating polycystic ovary syndrome in adolescence[J]. Shaanxi Traditional Chinese Medicine, 2020, 41(02): 234-237.

[18] Feng Xiao, Xu Zhaoxia, Feng Lu, et al. Advances in Chinese medicine evidence and treatment of liver-depressed polycystic ovary syndrome[J]. World Science and Technology - Modernization of Chinese Medicine, 2020, 22(09): 3338-3343.

[19] Zhang Yang, Nie Yanyan, Zhang Yuehui, et al. Examples of Professor Wang Xiuxia's experience in the staged treatment of polycystic ovary syndrome[J]. Chinese Family Planning and Obstetrics and Gynecology, 2019, 11(06): 6-7.

[20] Dong Li, Lian Fang, Wu Haicui. Professor Lian Fang's experience in the treatment of obese polycystic ovary syndrome[J]. Shi-Zhen Guomao, 2021, 32(04): 973-975.

[21] Li Yanqiu, Yuan Chengkun, Hou Lihui. Summary of clinical experience of Professor Hou Lihui in treating polycystic ovary syndrome[J]. Journal of Traditional Chinese Medicine, 2016, 44(01): 115-117.

[22] Xie Wei, Niu Jianzhao, Xue Xiaoou. Gleanings from Professor Niu Jianzhao's experience in treating polycystic ovary syndrome[J]. Shaanxi Traditional Chinese Medicine, 2017, 38(12): 1763-1764.

[23] Ge Yiting. Xu Xiaofeng's experience in treating infertility caused by polycystic ovary syndrome[J]. Jiangsu Traditional Chinese Medicine, 2022, 54(03): 28-31.

[24] Zhao BoLing, Hou LiHui. Analysis of the correlation between Chinese medicine constitution and polycystic ovary syndrome[J]. World abstract of the latest medical information, 2019, 19(35): 242+244.

[25] Huang Weiyu. A study on the distribution of TCM constitution in patients with polycystic ovary syndrome[J]. Inner Mongolia Traditional Chinese Medicine, 2019, 38(04): 127-128.

[26] Xiong Mengxin, Xiang Nan, Zhou Yana, et al. Study on the academic thought and treatment rules of Professor Jiang Huizhong in the treatment of polycystic ovary syndrome[J]. World Science and Technology - Modernization of Traditional Chinese Medicine, 2020, 22(11): 4001-4008.

[27] Tang Peipei, Tan Yong. A literature study on the distribution pattern of evidence types and evidence elements in polycystic ovary syndrome[J]. Jiangsu Traditional Chinese Medicine, 2017, 49(01): 66-68.

[28] Yi Sha, Liu Yanxia, Wang Yang, et al. A preliminary investigation of the distribution pattern of Chinese medicine evidence elements in the main clinical manifestations and biochemical characteristics of polycystic ovary syndrome[J]. Journal of Modern Traditional Chinese and Western Medicine, 2021, 30(29): 3206-3211.

[29] Li Yaqian, Yu Chaoqin, Zhai Dongxia, et al. A preliminary study on the pattern of Chinese medicine evidence based on literature on polycystic ovary syndrome[J]. Chinese Journal of Basic Chinese Medicine, 2015, 21(09): 1081-1082.

[30] Liu Xinmin, Hua Qiang. Exploring the distribution characteristics of TCM symptoms and elements of symptoms in polycystic ovary syndrome from modern literature[J]. Chinese Journal of Traditional Chinese Medicine Information, 2011, 18(02): 34-36.

[31] Qiao Shicong, Xia Min, Hou Lihui, et al. Study on the distribution characteristics of Chinese medical evidence in patients with polycystic ovary syndrome and clinical characteristics of patients with each evidence type[J]. Journal of Practical Medicine, 2018, 34(04): 653-656+664.

[32] Fang Qunying, Wu Limin, Sun Xiuying, et al. Study on the distribution pattern of Chinese medical evidence in infertile patients with polycystic ovary syndrome[J]. Shi-Zhen Guomao, 2018, 29(12): 3067-3070.

[33] Ma Jiawen, Jin Yuqi, Zhang Yizhou. Analysis of the literature on the pattern of Chinese medicine prescriptions for polycystic ovary syndrome based on cluster analysis[J]. Zhejiang Journal of Traditional Chinese Medicine, 2021, 56(08): 615.

[34] Huang Jinzhu, Li Yunlu, Huang Yefang, et al. Study on the distribution law of TCM clinical syndromes in 215 cases of polycystic ovary syndrome [J]. Shi Zhen Chinese Medicine and Chinese Medicine, 2015, 26(07): 1711-1712.

[35] Tian Lixia, Jiang Dan, Yang Jin, et al. Effects of Cu Pai Decoction on insulin resistance in rats with polycystic ovary syndrome [J]. Chinese Patent Medicine, 2021, 43(06): 1627-1631.

[36] Xu Lianwei, Ni Xiaorong, Ye Yumei, et al. Treatment of 78 cases of polycystic ovary syndrome with invigorating kidney and promoting blood circulation and regulating circulation[J]. Shaanxi Chinese Journal of Traditional Chinese Medicine, 2009, 30(03): 274-275.

[37] Wu Hangfei. Effect of Danzhi Xiaoyao Capsule on ovulation induction in polycystic ovary syndrome caused by liver stagnation and fire [J]. Electronic Journal of Practical Gynecology and Endocrinology, 2019, 6(35): 71-73+116.

[38] Lu Yan, Wang Xiaoyun. The mechanism of network pharmacology of Kidney Return Pill in the treatment of polycystic ovary syndrome [J]. New Chinese Materia Medica and Clinical Pharmacology, 2021, 32(06): 825-833.

[39] Xiao Cailan, Zhou Weiwan, Jiang Zhaomin. Clinical study on the treatment of polycystic ovary syndrome with Bushen Huoxue Decoction and Yanggong Decoction [J]. Shaanxi Chinese Journal of Traditional Chinese Medicine, 2021, 42(11): 1561-1564.

[40] Xu Rongqian, Liu Yun, Lin Shu. Observation on the efficacy of Zishen Yutai Pill in the treatment of infertility with polycystic ovary syndrome due to kidney-yang deficiency [J]. Fujian Chinese Medicine, 2021, 52(11): 56-57.

[41] Chen Qi, Yu Siyun, Yang Fengyun, et al. Observation on the effect of Yishencupai recipe in the treatment of polycystic ovary syndrome due to kidney deficiency and phlegm stasis [J]. Journal of Practical Clinical Medicine, 2021, 25(23): 99-102.

[42] Liu Yuan, Zhao Hengxia, Chen Ye, et al. Clinical observation of Fu's Plus Flavor Buzhong Yiqi Decoction in the treatment of polycystic ovary syndrome due to spleen deficiency and phlegm dampness [J]. Liaoning Journal of Traditional Chinese Medicine, 2022, 49(07): 86-89.